Vaxart Inc Revenue per Employee (VXRT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vaxart Inc   (VXRT)
 

Vaxart Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Vaxart Inc 's Revenue per employee fell on a trailing twelve month basis to $ 2,788,785, below the company average number of $524,615.
Within the Healthcare sector Employees of 10 other companies have achieved higher revenue per employee. While Vaxart Inc 's total ranking has deteriorated compared to the previous quarter from 168 to 233. Vaxart Inc has 65 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VXRT Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -85.33 % -31.58 % 87.9 % 586.46 % 1367.93 %
Sales per Employee (TTM) $ 2,788,785 3,739,446 3,932,446 3,650,123 2,280,062
VXRT's Total Ranking # 233 # 168 # 209 # 284 #
Seq. Revenue Change -60.93 % -30.7 % -62.37 % 43.95 % 82.26 %

VXRT Company Profile >> Back to VXRT Efficiency Comparisons >> Compare VXRT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 11
Overall Market # 233

Revenue per Employee Statistics
High Average Low
$ 3,932,446 $ 524,615 $ 7,246
(Mar 31 2026)   (Mar 31 2022)



Financial Statements
Vaxart Inc 's Revenue MRQ $ 11 Millions Visit VXRT's Income Statement
Vaxart Inc 's Revenues TTM $ 181 Millions Visit VXRT's aggregate revenue growth
What are VXRT's Sales? Visit VXRT's Sales by Segment




Other Ratios
Vaxart Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VXRT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VXRT's Competitors
Revenue per Employee for VXRT's Suppliers
Revenue per Employee for VXRT's Customers

You may also want to know
VXRT's Sales Growth Rates VXRT's Pe Price to earnings ratio VXRT's Receivables Turnover Ratio VXRT's Stock Quote
VXRT's Net Income Growth Rates VXRT's Ps Price to Sales ratio VXRT's Sales per Employee VXRT's Asset Turnover Ratio
VXRT's Net Margin VXRT's Pb Price to Book ratio VXRT's Financial Strength Ratios VXRT's Dividend Payout Ratio
Date modified: 2026-11-06T09:29:50+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.